Eliaz P. Babaev, Ph.D., Co-Founded Arobella Medical, LLC in 2006 and serves as its Chief Executive Officer and President. Dr. Babaev Co-founded Celleration Inc. and served as its Chief Technical Officer until July 2009 and Chief Executive Officer. Dr. Babaev worked as an ultrasound system design engineer and research scientist for DiaSorin, Inc., SpectRx, and AeroPag-USA, Inc. He served as the Head of Biomedical Engineering Laboratory and a Professor for State Technical University, Baku, USSR for 25 years. Dr. Babaev then immigrated to the U.S. in 1994 and worked as a senior technical consultant for several medical device companies. He served as Assistant Professor in the Biomedical Engineering Department of Bauman Moscow State Technical University. He has also been a Research Fellow in Biomechanics and Bioengineering at the Warsaw University of Technology and Bulgarian Academy of Sciences. Dr. Babaev graduated from Moscow-Bauman Technical University with a Ph.D. in Biomedical Engineering and Biomechanical Engineering in 1975. Dr. Babaev holds D.Sc. (Doctor of Science), Biomedical Engineering (Medical Ultrasound) in 1993 and D.Sc., Biomedical Instrumentations and Biomechanics from Latvian Academy of Science, Center For Biomechanics & Biomedical Engineering Riga, Latvia in 1991. He received B.S. and M.S. Degree in Mechanical Engineering (Industrial Ultrasound - NDT for Oil Reservoirs) in Azerbaijan Technical University Baku, Azerbaijan in 1969. Dr. Babaev has more than 40+ years expertise in Non-Imaging Medical Ultrasound and particularly in Ultrasound Wound Management, live tissue repair and in all the areas of advances in skin, wound care, nursing, tissue science, drug delivery systems, wound treatment technologies, tissue engineering, and body architectonics research and cancer research including apoptosis. 50+ US and 100+ Worldwide Patents are issued, numerous are pending, 50+ scientific articles, abstracts are published.
Ultrasound Wound Management, live tissue repair and in all the areas of advances in skin, wound care, nursing, tissue science, drug delivery systems, wound treatment technologies, tissue engineering, and body architectonics research and cancer research including apoptosis.
Joseph Krieger offers over 25-years of healthcare experience and 10-years of laboratory science background in biochemistry. Joseph was educated at Boston University School of Medicine, and is a graduate of University of Massachusetts, Amherst. He has holded positions such as President of Interventional Pain Management Techniques, Business development Director in Cedara Software and Sales Manager and Director in Radionics. Joseph’s experience includes management, product management, sales and marketing, regulatory affairs, minimally invasive surgery, image guided surgical navigation, medical imaging, software imaging for medical technologies and minimally invasive surgical devices. Joseph has created and executed hundreds of hands-on training programs for physicians and healthcare professionals in various medical markets. Several of these markets include Interventional Pain Management. Joseph is currently the President, Boston BioLife, which creates hands-on training and education programs in translational medicine for healthcare physicians, including stem cells and biologics in musculoskeletal medicine.
Biochemistry, Pain Management, Medical Imaging
Jasmina Begic is a Medical Consultant for BIOPTRON, Zepter Internastional for Bosnia and Herzegovina, Founder of Association for Wound management in B&H, Founder and author of Euro-Asian Forum, one of founder of www.BALWMA.org. She is currently working as a Dermatovenerologyst in Bioptron International team-Wound Healing and also a certified VCC trainer of elderly care; certified VCC trainer of manager EU founds; certified practitioner of TCM; certified practitioner of herbal medicine. She finished her graduation and post-graduation studies at Medical School of University Sarajevo, Sarajevo, Bosnia and Herzegovina and completed her PhD in the field of Tissue Regeneration and Wound Healing from Indian Institute of Technology, Kharagpur. She did volunteer works in Association for Wound management in Bosnia and Herzegovina (AWMinB&H) from 2008 till present. She is also active member in UEMS TF WH, EWMA, EADV. Her projects are involved in Clinical Research “Appliance Bioptron polarized light (480 -3400nm) in the therapy of dermatosis: Acne vulgaris and Ulcer cruris” which is approved by members of Scientifically Research Institute of Clinical Center of University in Sarajevo and Members of Ethics Commitee of Clinical Center University in Sarajevo; Euro-Asian Forum of Association for Wound Management (2011, 2012, 2014, 2016, 2018); Academy for health and social occupation (2013); Implementation of Traditional Chinese Medicine in health and stationary institution in Bosnia and Herzegovina and country of Western Balkan (2014); Balkan Wound Management Association (2015); Integrative Medicine in Postoperative Management (2017); Integrative medicine: Prevention is best cure of Pressure Ulcers (2017).
Bruce Werber is currently acting as the President of BioStem Life Sciences tissue bank. From 2011 to 2016, he served as a consultant of medical and surgical industries of Cuboid Associates. From 1981 to 2014, he practiced as a Board-Certified reconstructive foot and ankle surgeon in Rhode Island and then in Arizona, the CEO of several medical practices 1981 until 2017. In 2012, he founded and, from 2012 to 2015, served as the President of Amnio Technology LLC, creating the company as well as developing the processing and clinical science related to utilizing placental tissue in orthopedic medicine. Prior to founding Amnio Technology, he wrote and published two peer reviewed papers relating to using placental tissue in the treatment of diabetic wounds, plantar fasciosis and Achilles tendinosis. He has spoken and lectured on this topic extensively around the United States and internationally. He has completed surgical fellowships in 2003 from Athens Institute for Orthopedics in Athens Greece, 2002/04 at the Ilizarov Institute in Kurgan Russia, and in 1989 Hadassah Hospital Jerusalem Israel. He was developing expertise in limb preservation techniques most notably reconstruction of the Charcot Foot with external fixation. Also, teaching positions of Professor at Midwestern University in Phoenix, AZ, and past faculty of Root Biomechanical Foundation. He has submitted eight patent applications in the area of placental tissue, six of which are still pending and two have been granted. Plus 2 additional patents in orthopedic implant designs. He served as the President of the American College of Foot and Ankle surgeons from 2003 to 2004. He has been a leader in the field of foot and ankle surgery, introducing new successful technologies to improve patient outcomes. His extensive business experience includes the development of the Anu Life Sciences 2016 thru 2017 which was acquired and became BioStem Life Sciences, in addition to founding and managing successful medical practices in Rhode Island and Arizona. He earned his DPM (Doctor of Podiatric Medicine) in 1980 from the California College of Podiatric Medicine in San Francisco, CA, Biomedical engineering master’s at Brooklyn PolyTech 1977 and a B.S. in Biology-Physics in 1976 from Syracuse University in Syracuse, NY.
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at the cause of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialization of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialization and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialization of human organs using graphene-based nanocomposite materials and stem cells technology.
Elad Arieh Koren, RN, TVN, BsN, currently acting as Head of Geula Vascular ulcer clinic of Leumit HMO In Jerusalem, Israel. He graduated from Hadassah Nursing School at 2013. He is also the Founder and chairman of IWCMRA- Israeli Wound Care Management and Research Association. He has been working at the field of chronic wounds for the past five years at the community setting. He is also the active member of EWMA and working in collaboration with ISTAP. His research Interests includes studying and investigating the prevalence of venous ulcers among the Ultra-Orthodox community in Jerusalem as well as working as a skin-tear consultant and research understudy for a few old-age homes around the city.
Yavuz is the chairman of Istanbul Consulting Group. ICG(Istanbul Consulting Group) was founded in 2013 and provided guidance to the Turkish ministry of health as part of a World Bank project. Yavuz is currently the Co-Founder of BioCube ?stanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Sumitomo Group/ Expel ?laç Archem Diagnostics Ended and Diagen. He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and director of Avc?lar Hospital R&D Center, Chief Medical Officer of Lifematrix GmbH. Previously he worked as the Market Access & Health Policy Director for AIFD in Turkey. Yavuz previously worked as the Vice President of Ipsen pharmaceutical and Director of Teva pharmaceutical in the USA managing large clinical trials as well as Investigator Initiated Trials and developing relationships with Key Opinion Leaders. Previously, Yavuz was the Associate Director at KV Pharmaceuticals and Director in Clinical Development department at Forest Laboratories. Yavuz earned his MD from the Faculty of Medicine, the University of Ankara in Ankara, Turkey. He completed a clinical internship at Baylor College of Medicine in Houston, followed by continued research training at The University of Texas MD Anderson Cancer Center in Houston. He recently completed his Executive MBA at the Olin Business School at Washington University in St. Louis.